Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cerebral autoregulation is the fundamental mechanism that regulates cerebral blood flow in the face of blood pressure variability. It is a dynamic process that depends on vascular smooth muscle cell contractile function, driven by myogenic, chemical and autonomic mechanisms. Cerebral small vessel disease (cSVD) is associated with increased blood pressure variation due systemic haemodynamic dysfunction, as well as dysfunction of the cerebral small vessels, characterised by endothelial dysfunction and vascular reactivity. As such, cerebral autoregulation may be impaired in cSVD, either as a manifestation of the disease or as a cause. This narrative review addresses current clinical evidence for involvement of autoregulatory dysfunction in cSVD. It discusses the mechanisms of autoregulation; how these overlap with vascular mechanisms involved in cSVD; methods of measurement of autoregulation these patients; evidence for altered autoregulation in patients with either sporadic cSVD, previous stroke or specific forms of cSVD; and effects of potential therapies for cSVD on autoregulation. This review thereby identifies the potential importance of autoregulation in cSVD, highlights current limitations in our understanding, and outlines future research avenues.

More information Original publication

DOI

10.1177/17474930261456372

Type

Journal article

Publication Date

2026-05-23T00:00:00+00:00

Keywords

Autoregulation, Myogenic, Small Vessel Disease, Treatments, Vascular Cognitive Impairment, White matter hyperintensities